These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 38753753)

  • 21. Molecular Imaging and Therapy for Neuroendocrine Tumors.
    Desai H; Borges-Neto S; Wong TZ
    Curr Treat Options Oncol; 2019 Aug; 20(10):78. PubMed ID: 31468190
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuroendocrine tumor theranostics.
    Ichikawa Y; Kobayashi N; Takano S; Kato I; Endo K; Inoue T
    Cancer Sci; 2022 Jun; 113(6):1930-1938. PubMed ID: 35271754
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of Gastroenteropancreatic Neuroendocrine Tumors.
    Perez K; Chan J
    Surg Pathol Clin; 2019 Dec; 12(4):1045-1053. PubMed ID: 31672293
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuroendocrine Tumor Theranostics: An Update and Emerging Applications in Clinical Practice.
    Sheikhbahaei S; Sadaghiani MS; Rowe SP; Solnes LB
    AJR Am J Roentgenol; 2021 Aug; 217(2):495-506. PubMed ID: 34076455
    [No Abstract]   [Full Text] [Related]  

  • 25. Role of somatostatins in gastroenteropancreatic neuroendocrine tumor development and therapy.
    Oberg KE; Reubi JC; Kwekkeboom DJ; Krenning EP
    Gastroenterology; 2010 Sep; 139(3):742-53, 753.e1. PubMed ID: 20637207
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Gastroenteropancreatic neuroendocrine tumors : targeted diagnostics and therapy].
    Holzer K
    Chirurg; 2014 Aug; 85(8):731-44. PubMed ID: 25103842
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gastroenteropancreatic Neuroendocrine Tumors.
    Cives M; Strosberg JR
    CA Cancer J Clin; 2018 Nov; 68(6):471-487. PubMed ID: 30295930
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Theranostics in neuroendocrine tumours: somatostatin receptor imaging and therapy.
    Pencharz D; Gnanasegaran G; Navalkissoor S
    Br J Radiol; 2018 Nov; 91(1091):20180108. PubMed ID: 30102557
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Search for an Alternative to [
    Waldmann CM; Stuparu AD; van Dam RM; Slavik R
    Theranostics; 2019; 9(5):1336-1347. PubMed ID: 30867834
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular imaging Theranostics of Neuroendocrine Tumors.
    Fortunati E; Bonazzi N; Zanoni L; Fanti S; Ambrosini V
    Semin Nucl Med; 2023 Jul; 53(4):539-554. PubMed ID: 36623974
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Consensus on molecular imaging and theranostics in neuroendocrine neoplasms.
    Ambrosini V; Kunikowska J; Baudin E; Bodei L; Bouvier C; Capdevila J; Cremonesi M; de Herder WW; Dromain C; Falconi M; Fani M; Fanti S; Hicks RJ; Kabasakal L; Kaltsas G; Lewington V; Minozzi S; Cinquini M; Öberg K; Oyen WJG; O'Toole D; Pavel M; Ruszniewski P; Scarpa A; Strosberg J; Sundin A; Taïeb D; Virgolini I; Wild D; Herrmann K; Yao J
    Eur J Cancer; 2021 Mar; 146():56-73. PubMed ID: 33588146
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular Imaging of Gastroenteropancreatic Neuroendocrine Tumors: Current Status and Future Directions.
    Deroose CM; Hindié E; Kebebew E; Goichot B; Pacak K; Taïeb D; Imperiale A
    J Nucl Med; 2016 Dec; 57(12):1949-1956. PubMed ID: 27811124
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuroendocrine Tumors: Diagnostics.
    Sakellis C; Jacene HA
    PET Clin; 2024 Jul; 19(3):325-339. PubMed ID: 38714399
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gastroenteropancreatic neuroendocrine tumours (GEP-NET) - Imaging and staging.
    Baumann T; Rottenburger C; Nicolas G; Wild D
    Best Pract Res Clin Endocrinol Metab; 2016 Jan; 30(1):45-57. PubMed ID: 26971843
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overview and Current Status of Peptide Receptor Radionuclide Therapy.
    Bushnell DL; Bodeker KL
    Surg Oncol Clin N Am; 2020 Apr; 29(2):317-326. PubMed ID: 32151363
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patient selection for personalized peptide receptor radionuclide therapy using Ga-68 somatostatin receptor PET/CT.
    Kulkarni HR; Baum RP
    PET Clin; 2014 Jan; 9(1):83-90. PubMed ID: 25029937
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peptide receptor therapies in neuroendocrine tumors.
    Bodei L; Ferone D; Grana CM; Cremonesi M; Signore A; Dierckx RA; Paganelli G
    J Endocrinol Invest; 2009 Apr; 32(4):360-9. PubMed ID: 19636207
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radiological and nuclear medicine imaging of gastroenteropancreatic neuroendocrine tumours.
    Sundin A
    Best Pract Res Clin Gastroenterol; 2012 Dec; 26(6):803-18. PubMed ID: 23582920
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advances and Current Concepts in the Medical Management of Gastroenteropancreatic Neuroendocrine Neoplasms.
    Alexandraki KI; Karapanagioti A; Karoumpalis I; Boutzios G; Kaltsas GA
    Biomed Res Int; 2017; 2017():9856140. PubMed ID: 29349087
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular and Anatomic Imaging of Neuroendocrine Tumors.
    Szidonya L; Park EA; Kwak JJ; Mallak N
    Surg Oncol Clin N Am; 2022 Oct; 31(4):649-671. PubMed ID: 36243499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.